InvestorsHub Logo
Followers 105
Posts 12416
Boards Moderated 0
Alias Born 11/23/2006

Re: None

Monday, 03/05/2018 10:50:55 AM

Monday, March 05, 2018 10:50:55 AM

Post# of 458742
“We are delighted to welcome Stephan and Claus to Anavex. These appointments are a commitment to building our team in order to advance the development of ANAVEX2-73 in devastating neurological diseases like Rett syndrome, Alzheimer’s disease and Parkinson’s disease. Stephan is a seasoned business leader and an experienced operations and marketing executive who will lead the acceleration of our product development strategy, while Claus’ expertise will provide strategic guidance, compliance and accounting oversight on the Board of Directors,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

The POWER of the Internet. Like the Six Gun in the Old West called an Equalizer.
Do your own DD, This post is my OPINION. ** TRUST, BUT VERIFY.**VERIFY

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News